Zyrtec Model Shows Managed Care’s “Softer” Side For Switching Patients

Sales of Johnson & Johnson's allergy drug Zyrtec show managed care organizations learned from previous switches and used a "softer" approach to steer clients away from Rx drugs to an OTC product, according to market analysts